Research Topic · Peer-Reviewed

Multiple Myeloma

Multiple Myeloma is a type of cancer that affects the plasma cells in the body. These cells are a type of white blood cells that are important for fighting infection. Multiple Myeloma is a serious, life-threatening cancer that is usually diagnosed in people over 50. It can cause bone pain and weakness, as well as an…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 39× across the literature 🗓 Reviewed June 2026

Overview

Multiple Myeloma is a type of cancer that affects the plasma cells in the body. These cells are a type of white blood cells that are important for fighting infection. Multiple Myeloma is a serious, life-threatening cancer that is usually diagnosed in people over 50. It can cause bone pain and weakness, as well as anemia, kidney problems, and infections. Treatment options include chemotherapy, radiation, and bone marrow or stem cell transplants. In some cases, medications such as monoclonal antibodies or targeted therapies can be used to slow the progression of this disease. Early diagnosis and treatment are important for improving the outlook for multiple myeloma patients.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 12 articles above have been cited 39 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Multiple Myeloma, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Advances in Leukemia.

Journal editorial board
Hang Su · United States Ewelina Grywalska · Poland Antonio Ruggiero · Italy

This page summarises published research for orientation; it is not medical or professional advice.